Key result
One year of Alagebrium combined with moderate-intensity exercise had no synergistic effect on exercise stroke index or effective arterial elastance in seniors (interaction P≥0.252).
Why the study?
Does Alagebrium combined with moderate-intensity exercise improve left ventricular function during exercise in seniors?
RCT (n=86)
Randomized into four groups
Does Alagebrium combined with moderate-intensity exercise improve left ventricular function during exercise in seniors?
In seniors, 1 year of moderate-intensity exercise improves left ventricular function, but the addition of the advanced glycation end-product cross-link breaker Alagebrium provides no synergistic benefit.
Adding Alagebrium confers no synergistic benefit on exercise-induced LV improvements in seniors; challenges AGE-breaker adjunct therapy and extends evidence for exercise monotherapy.
Sedentary aging leads to left ventricular (LV) and vascular stiffening due in part to advanced glycation end-products (AGEs) cross-linking of extracellular matrix proteins. Vigorous lifelong exercise ameliorates age-related cardiovascular (CV) stiffening and enhances exercise LV function, although this effect is limited when exercise is initiated later in life. We hypothesized that exercise training might be more effective at improving the impact of age-related CV stiffening during exercise when combined with an AGE cross-link breaker (Alagebrium). Sixty-two seniors (≥60 yr) were randomized into four groups: sedentary + placebo, sedentary + Alagebrium, exercise + placebo, and exercise + Alagebrium for 1 yr. Moderate-intensity aerobic exercise was performed 3-4 sessions/wk; controls underwent similar frequency of yoga/balance training. Twenty-four similarly-aged, lifelong exercisers (4-5 sessions/wk) served as a comparator for the effect of lifelong exercise on exercising LV function. Oxygen uptake (Douglas bags), stroke index (SI; acetylene rebreathing), and effective arterial elastance (Ea) were collected at rest and submaximal and maximal exercise. Maximum O2 uptake (23 ± 5 to 25 ± 6 ml·kg(-1)·min(-1)) increased, while SI (35 ± 11 to 39 ± 12 ml/m(2)) and Ea (4.0 ± 1.1 to 3.7 ± 1.2 mmHg·ml(-1)·m(-2)) were improved across all conditions with exercise, but remained unchanged in controls (exercise × time, P ≤ 0.018). SI or Ea were not affected by Alagebrium (medication × time, P ≥ 0.468) or its combination with exercise (interaction P ≥ 0.252). After 1 yr of exercise plus Alagebrium, exercise SI and Ea remained substantially below that of lifelong exercisers (15-24 and 9-22%, respectively, P ≤ 0.415). In conclusion, Alagebrium plus exercise had no synergistic effect on exercise LV function and failed to achieve levels associated with lifelong exercise, despite a similar exercise frequency.
No takes yet. Share an insight, caveat, or question.
Carrick‐Ranson et al. (2016) conducted an RCT in Sedentary aging (n=86). Alagebrium and moderate-intensity exercise vs. Sedentary + placebo, sedentary + Alagebrium, exercise + placebo was evaluated on Stroke index (SI) and effective arterial elastance (Ea) during exercise (p=≥0.252). One year of Alagebrium combined with moderate-intensity exercise had no synergistic effect on exercise stroke index or effective arterial elastance in seniors (interaction P≥0.252).
Synapse has enriched 5 related papers. Consider them for comparative context: